Edwards Lifesciences Corporation (EW)

NYSE: EW · Real-Time Price · USD

86.29

+0.56 (0.65%)

At close: Sep 25, 2026, 4:00 PM EDT

85.50

-0.79 (-0.92%)

After-hours: Sep 25, 2026, 7:30 PM EDT

Edwards Lifesciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	49,738	49,471	43,663	46,246	46,128	80,883
Market Cap Growth	13.47%	13.30%	-5.58%	0.25%	-42.97%	42.25%
Enterprise Value	46,160	46,323	39,982	45,142	45,077	79,772
Last Close Price	86.29	85.25	74.03	76.25	74.61	129.55

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	51.48	46.08	10.46	32.98	30.31	53.81
Forward PE	27.48	30.93	31.19	28.41	30.35	52.98
PS Ratio	7.64	8.15	8.03	9.23	10.33	15.46
PB Ratio	4.69	4.79	4.34	6.88	7.94	13.86
P/TBV Ratio	6.83	6.65	6.20	9.06	10.59	18.62
P/FCF Ratio	34.69	37.06	150.61	71.94	47.38	57.51
P/OCF Ratio	28.91	31.01	80.51	51.63	37.87	46.70
PEG Ratio	2.26	3.24	3.69	2.77	2.95	3.38

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	7.09	7.63	7.35	9.01	10.10	15.25
EV/EBITDA Ratio	23.12	25.81	24.62	28.05	26.81	46.34
EV/EBIT Ratio	25.21	28.28	27.00	30.35	29.24	50.28
EV/FCF Ratio	32.20	34.70	137.92	70.23	46.30	56.73

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.07	0.07	0.07	0.10	0.12	0.12
Debt / EBITDA Ratio	0.35	0.39	0.42	0.42	0.40	0.39
Debt / FCF Ratio	0.49	0.53	2.42	1.07	0.71	0.49
Net Debt / Equity Ratio	-0.33	-0.34	-0.33	-0.14	-0.09	-0.13
Net Debt / EBITDA Ratio	-1.79	-1.97	-2.02	-0.59	-0.31	-0.45
Net Debt / FCF Ratio	-2.49	-2.64	-11.32	-1.47	-0.54	-0.55
Asset Turnover	0.48	0.45	0.49	0.57	0.53	0.67
Inventory Turnover	1.27	1.21	1.12	1.10	0.90	1.63
Quick Ratio	3.45	2.83	3.13	2.06	1.87	2.07
Current Ratio	4.52	3.72	4.18	3.38	3.03	3.08
Return on Equity (ROE)	9.18%	10.35%	16.64%	19.48%	22.74%	28.88%
Return on Assets (ROA)	8.37%	7.65%	8.26%	10.53%	11.47%	12.60%
Return on Invested Capital (ROIC)	17.39%	19.98%	21.26%	23.92%	25.98%	31.39%
Return on Capital Employed (ROCE)	14.80%	13.80%	12.80%	18.20%	21.20%	21.20%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	2.02%	2.17%	9.56%	3.03%	3.30%	1.86%
FCF Yield	2.88%	2.70%	0.66%	1.39%	2.11%	1.74%
Buyback Yield / Dilution	1.64%	2.25%	1.66%	2.37%	1.11%	0.11%

SEC Filings: 10-K · 10-Q